-
Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting
24 Apr 2024 17:58 GMT
… in non-small cell lung cancer (NSCLC) with epidermal … or refractory non-small cell lung cancer (NSCLC) harboring EGFR … for the treatment of lung cancer patients with EGFR exon20ins … 8563 Poster Session Lung Cancer – Non-Small Cell Metastatic June 3, 2024 …
-
Systemic Treatment Options for Non-Small Cell Lung Cancer
24 Apr 2024 17:53 GMT
Christine Bestvina, MD, presents her treatment strategy for a 62-year-old female with NSCLC, bone and liver metastases, and an EGFR exon 20 insertion; the panel then assesses clinical data, including the MARIPOSA trial, to guide their treatment decisions.
-
'We Need to Rethink Our Options': Lung Cancer Recurrence
24 Apr 2024 17:14 GMT
… after attending the New York Lung Cancer Foundation Summit here in New … , as systemic therapy has controlled metastatic disease, is recurrence in the …
-
Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
24 Apr 2024 14:54 GMT
… in brain metastases from non-small cell lung cancer (NSCLC) … with 1-10 brain metastases from NSCLC. In March … Patients with brain metastases from non-small cell lung cancer need more … the Treatment of Metastatic Non-Small Cell Lung Cancer. Abstract TPS8665. …
-
Machine Learning in Diagnosis and Prognosis of Lung Cancer by PET-CT
24 Apr 2024 03:06 GMT
… lung tumors, especially lung cancer lesions, due to the influence of respiratory movement, the lung tumors … tracers for lung cancer. Lung Cancer. 2016;94 … , node, metastasis staging of lung cancer (8(th … with lung cancer recurrence after surgery. Lung Cancer. …
-
Tislelizumab Earns European Approval in Non–Small Cell Lung Cancer
23 Apr 2024 17:43 GMT
… or those who have metastatic disease.
Additionally, the … treatment for non-small cell lung cancer. News release. BeiGene, … squamous non–small-cell lung cancer: a phase 3 randomized … treatment for non-small cell lung cancer. News release. BeiGene, Ltd …
-
Research Progress of Baihe Gujin Decoction in the Treatment of Lung Cancer
23 Apr 2024 17:30 GMT
… -small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) … its effectiveness in combating lung cancers. More importantly, through … in lung cancer. In the study on 84 lung cancer patients … to the proliferation and metastasis of lung cancer. To sum up, …
-
Krystal Biotech doses first subject in lung cancer drug trial
23 Apr 2024 11:50 GMT
… patients with locally advanced or metastatic solid lung tumours.
A modified HSV-1 … solid tumour patients with pulmonary metastases that have relapsed or are …
-
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
23 Apr 2024 10:17 GMT
… treatment for non-small cell lung cancer (NSCLC) across three indications … platinum-based chemoradiation, or metastatic NSCLC.
In combination with … .
“Non-small cell lung cancer remains one of the … related death worldwide.1 Lung cancer is the third most …
-
AFNT-211 by Affini-T Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
23 Apr 2024 03:29 GMT
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role …